Giuseppe Floresta

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 55

Top Topics

Walled Carbon Nanotubes

Chronic Myeloid Leukemia

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Michele Larocca, Giuseppe Floresta, Daniele Verderese, Agostino Cilibrizzi
Dominant Chemical Interactions Governing the Folding Mechanism of Oligopeptides. International journal of molecular sciences 25 (17) (2024)
Vincenzo Patamia, Erika Saccullo, Virginia Fuochi, Federica Magaletti, Luca Trecarichi, Salvatore Furnari, Pio Maria Furneri, Vincenzina Barbera, Giuseppe Floresta, Antonio Rescifina
Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization. ACS applied bio materials (2024)
Davide Arillotta, Giuseppe Floresta, G Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. Brain sciences 14 (6) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Davide Arillotta, Giuseppe Floresta, G Duccio Papanti Pelletier, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach. Brain sciences 14 (6) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John Martin Corkery, Jacqueline L Stair, Fabrizio Schifano, Amira Guirguis
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques. Pharmacy (Basel, Switzerland) 12 (1) (2024)
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L Sensi, Fabrizio Schifano
GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain sciences 13 (11) (2023)
Vincenzo Patamia, Giuseppe Floresta, Chiara Zagni, Venerando Pistarà, Francesco Punzo, Antonio Rescifina
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study. International journal of molecular sciences 24 (2) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Mariacristina Failla, Giuseppe Floresta, Vincenzo Abbate
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling. RSC medicinal chemistry 14 (4) (2023)
Giuseppe Floresta, Letizia Crocetti, Renan Rodrigues de Oliveira Silva, Vincenzo Patamia, Francesca Mazzacuva, Yu Chee Sonia Chen, Claudia Vergelli, Agostino Cilibrizzi
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors. Archiv der Pharmazie (2023)
Chiara Zagni, Andrea Antonino Scamporrino, Paolo Maria Riccobene, Giuseppe Floresta, Vincenzo Patamia, Antonio Rescifina, Sabrina Carola Carroccio
Portable Nanocomposite System for Wound Healing in Space. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Virginia Fuochi, Giuseppe Floresta, Rosalia Emma, Vincenzo Patamia, Massimo Caruso, Chiara Zagni, Federica Ronchi, Celestino Ronchi, Filippo Drago, Antonio Rescifina, Pio Maria Furneri
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43. Viruses 15 (3) (2023)
Chiara Zagni, Andrea Antonino Scamporrino, Paolo Maria Riccobene, Giuseppe Floresta, Vincenzo Patamia, Antonio Rescifina, Sabrina Carola Carroccio
Portable Nanocomposite System for Wound Healing in Space. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Chiara Zagni, Andrea Antonino Scamporrino, Paolo Maria Riccobene, Giuseppe Floresta, Vincenzo Patamia, Antonio Rescifina, Sabrina Carola Carroccio
Portable Nanocomposite System for Wound Healing in Space. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Vincenzo Patamia, Giuseppe Floresta, Chiara Zagni, Venerando Pistarà, Francesco Punzo, Antonio Rescifina
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study. International journal of molecular sciences 24 (2) (2023)
Mariacristina Failla, Giuseppe Floresta, Vincenzo Abbate
Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling. RSC medicinal chemistry 14 (4) (2023)
Virginia Fuochi, Giuseppe Floresta, Rosalia Emma, Vincenzo Patamia, Massimo Caruso, Chiara Zagni, Federica Ronchi, Celestino Ronchi, Filippo Drago, Antonio Rescifina, Pio Maria Furneri
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43. Viruses 15 (3) (2023)
Giuseppe Floresta, Chiara Zagni, Vincenzo Patamia, Antonio Rescifina
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)? Expert opinion on drug discovery (2023)
Vincenzo Patamia, Chiara Zagni, Roberto Fiorenza, Virginia Fuochi, Sandro Dattilo, Paolo Maria Riccobene, Pio Maria Furneri, Giuseppe Floresta, Antonio Rescifina
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity. Nanomaterials (Basel, Switzerland) 13 (14) (2023)
Virginia Fuochi, Giuseppe Floresta, Rosalia Emma, Vincenzo Patamia, Massimo Caruso, Chiara Zagni, Federica Ronchi, Celestino Ronchi, Filippo Drago, Antonio Rescifina, Pio Maria Furneri
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43. Viruses 15 (3) (2023)
Vincenzo Patamia, Chiara Zagni, Ilaria Brullo, Erika Saccullo, Alessandro Coco, Giuseppe Floresta, Antonio Rescifina
Computer-Assisted Design of Peptide-Based Radiotracers. International journal of molecular sciences 24 (7) (2023)
Vincenzo Patamia, Giuseppe Floresta, Chiara Zagni, Venerando Pistarà, Francesco Punzo, Antonio Rescifina
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study. International journal of molecular sciences 24 (2) (2023)
Chiara Zagni, Andrea Antonino Scamporrino, Paolo Maria Riccobene, Giuseppe Floresta, Vincenzo Patamia, Antonio Rescifina, Sabrina Carola Carroccio
Portable Nanocomposite System for Wound Healing in Space. Nanomaterials (Basel, Switzerland) 13 (4) (2023)
Rosario Tomarchio, Vincenzo Patamia, Chiara Zagni, Letizia Crocetti, Agostino Cilibrizzi, Giuseppe Floresta, Antonio Rescifina
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors. Molecules (Basel, Switzerland) 28 (6) (2023)
Vincenzo Patamia, Giuseppe Floresta, Chiara Zagni, Venerando Pistarà, Francesco Punzo, Antonio Rescifina
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study. International journal of molecular sciences 24 (2) (2023)
Valeria Ciaffaglione, Valeria Consoli, Sebastiano Intagliata, Agostino Marrazzo, Giuseppe Romeo, Valeria Pittala, Khaled Greish, Luca Vanella, Giuseppe Floresta, Antonio Rescifina, Loredana Salerno, Sorrenti Valeria
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia. Molecules (Basel, Switzerland) 27 (10) (2022)
Giuseppe Floresta, Chiara Zagni, Davide Gentile, Vincenzo Patamia, Antonio Rescifina
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design. International journal of molecular sciences 23 (6) (2022)
Letizia Crocetti, Giuseppe Floresta, Agostino Cilibrizzi, Maria Paola Giovannoni
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022. Molecules (Basel, Switzerland) 27 (15) (2022)
Letizia Crocetti, Giuseppe Floresta, Chiara Zagni, Divya Merugu, Francesca Mazzacuva, Renan Rodrigues de Oliveira Silva, Claudia Vergelli, Maria Paola Giovannoni, Agostino Cilibrizzi
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2 H )-one as Novel Scaffold for FABP4 Inhibition. Pharmaceuticals (Basel, Switzerland) 15 (11) (2022)
Davide Gentile, Alessandro Coco, Vincenzo Patamia, Chiara Zagni, Giuseppe Floresta, Antonio Rescifina
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process. International journal of molecular sciences 23 (17) (2022)
Giuseppe Floresta, Siham Memdouh, Truc Pham, Michelle T Ma, Philip J Blower, Robert C Hider, Vincenzo Abbate, Agostino Cilibrizzi
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes. Dalton transactions (Cambridge, England : 2003) 51 (34) (2022)
Giuseppe Floresta, George P Keeling, Siham Memdouh, Levente K Meszaros, Rafael T M de Rosales, Vincenzo Abbate
NHS-Functionalized THP Derivative for Efficient Synthesis of Kit-Based Precursors for 68Ga Labeled PET Probes. Biomedicines 9 (4) (2021)
Giuseppe Floresta, Ivana Gavrilović, Scarlett Devey, Rhian Harris, David A Cowan, Vincenzo Abbate
Towards identifying nicomorphine administration in doping control: synthesis of metabolites. Bioanalysis 13 (18) (2021)
Giuseppe Floresta, Vincenzo Abbate
Machine learning vs. field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification. RSC advances 11 (24) (2021)
Giuseppe Floresta, Antonino Nicolò Fallica, Vincenzo Patamia, Sorrenti Valeria, Khaled Greish, Antonio Rescifina, Valeria Pittala
From Far West to East: Joining the Molecular Architecture of Imidazole-like Ligands in HO-1 Complexes. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Vincenzo Patamia, Giuseppe Floresta, Venerando Pistarà, Antonio Rescifina
Green Efficient One-Pot Synthesis and Separation of Nitrones in Water Assisted by a Self-Assembled Nanoreactor. International journal of molecular sciences 23 (1) (2021)
Davide Gentile, Giuseppe Floresta, Vincenzo Patamia, Angelo Nicosia, Placido Giuseppe Mineo, Antonio Rescifina
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water. Organic & biomolecular chemistry 18 (6) (2020)
Giuseppe Floresta, Nunzio Cardullo, Carmela Spatafora, Antonio Rescifina, Corrado Tringali
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion. International journal of molecular sciences 21 (18) (2020)
Valeria Ciaffaglione, Sebastiano Intagliata, Valeria Pittala, Agostino Marrazzo, Sorrenti Valeria, Luca Vanella, Antonio Rescifina, Giuseppe Floresta, Ameera Sultan, Khaled Greish, Loredana Salerno
New Arylethanolimidazole Derivatives as HO-1 Inhibitors with Cytotoxicity against MCF-7 Breast Cancer Cells. International journal of molecular sciences 21 (6) (2020)
Davide Gentile, Giuseppe Floresta, Vincenzo Patamia, Rita Chiaramonte, Giulia Letizia Mauro, Antonio Rescifina, Michele Vecchio
An Integrated Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin A Inhibitors. International journal of molecular sciences 21 (24) (2020)
Chiara Pennetta, Giuseppe Floresta, Adriana Carol Eleonora Graziano, Venera Cardile, Lucia Rubino, Maurizio Stefano Galimberti, Antonio Rescifina, Vincenzina Barbera
Functionalization of Single and Multi-Walled Carbon Nanotubes with Polypropylene Glycol Decorated Pyrrole for the Development of Doxorubicin Nano-Conveyors for Cancer Drug Delivery. Nanomaterials (Basel, Switzerland) 10 (6) (2020)
Giuseppe Floresta, Antonio Rescifina, Vincenzo Abbate
Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules. International journal of molecular sciences 20 (9) (2019)
Valentina Venuti, Vincenza Crupi, Barbara Fazio, Domenico Majolino, Giuseppe Acri, Barbara Testagrossa, Rosanna Stancanelli, Federica De Gaetano, Agnese Gagliardi, Donatella Paolino, Giuseppe Floresta, Venerando Pistarà, Antonio Rescifina, Cinzia Anna Ventura
Physicochemical Characterization and Antioxidant Activity Evaluation of Idebenone/Hydroxypropyl-β-Cyclodextrin Inclusion Complex †. Biomolecules 9 (10) (2019)
Giuseppe Floresta, Davide Gentile, Giancarlo Perrini, Vincenzo Patamia, Antonio Rescifina
Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach. Marine drugs 17 (11) (2019)
Pellegrino La Manna, Margherita De Rosa, Carmen Talotta, Antonio Rescifina, Giuseppe Floresta, Annunziata Soriente, Carmine Gaeta, Placido Neri
Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space. Angewandte Chemie (International ed. in English) 59 (2) (2019)
Giuseppe Floresta, Maria Dichiara, Davide Gentile, Orazio Prezzavento, Agostino Marrazzo, Antonio Rescifina, Emanuele Amata
Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands. International journal of molecular sciences 20 (3) (2019)
Giuseppe Floresta, Venerando Pistarà, Kirsten E Christensen, Emanuele Amata, Agostino Marrazzo, Davide Gentile, Antonio Rescifina, Francesco Punzo
A Pseudouridine Isoxazolidinyl Nucleoside Analogue Structural Analysis: A Morphological Approach. Molecules (Basel, Switzerland) 23 (12) (2018)
Giuseppe Floresta, Emanuele Amata, Maria Dichiara, Agostino Marrazzo, Loredana Salerno, Giuseppe Romeo, Orazio Prezzavento, Valeria Pittala, Antonio Rescifina
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis. ChemMedChem 13 (13) (2018)
Giuseppe Floresta, Orapan Apirakkan, Antonio Rescifina, Vincenzo Abbate
Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis. Molecules (Basel, Switzerland) 23 (9) (2018)
Khaled F Greish, Loredana Salerno, Reem Al Zahrani, Emanuele Amata, Maria N Modica, Giuseppe Romeo, Agostino Marrazzo, Orazio Prezzavento, Sorrenti Valeria, Antonio Rescifina, Giuseppe Floresta, Sebastiano Intagliata, Valeria Pittalà
Novel Structural Insight into Inhibitors of Heme Oxygenase-1 (HO-1) by New Imidazole-Based Compounds: Biochemical and In Vitro Anticancer Activity Evaluation. Molecules (Basel, Switzerland) 23 (5) (2018)
Giuseppe Floresta, Emanuele Amata, Carla Barbaraci, Davide Gentile, Rita Turnaturi, Agostino Marrazzo, Antonio Rescifina
A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands. Marine drugs 16 (10) (2018)
Pellegrino La Manna, Carmen Talotta, Giuseppe Floresta, Margherita De Rosa, Annunziata Soriente, Antonio Rescifina, Carmine Gaeta, Placido Neri
Mild Friedel-Crafts Reactions inside a Hexameric Resorcinarene Capsule: C-Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules. Angewandte Chemie (International ed. in English) 57 (19) (2018)